The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc shares valued at $228,375 were sold by Dickinson Andrew D on Jan 15 ’25. At $91.35 per share, Dickinson Andrew D sold 2,500 shares. The insider’s holdings dropped to 129,873 shares worth approximately $12.41 million following the completion of this transaction.
Also, ANDREW DICKINSON purchased 2,500 shares, netting a total of over 228,375 in proceeds.
Before that, GILEAD SCIENCES, INC. had added 940,499 shares to its account. In a trade valued at $20,098,464, the 10% Owner bought Gilead Sciences, Inc shares for $21.37 each. Upon closing the transaction, the insider’s holdings increased to 940,499 shares, worth approximately $211.2 million.
As published in a research note from Morgan Stanley on January 10, 2025, Gilead Sciences, Inc [GILD] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $113 from $87. As of November 15, 2024, Wolfe Research has initiated its “an Outperform” rating for GILD. Earlier on November 14, 2024, Citigroup initiated its rating. Their recommendation was “a Buy” for GILD stock.
Analyzing GILD Stock Performance
During the last five days, there has been a surge of approximately 2.74%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 3.49%. Shares of the company reached a 52-week high of $96.70 on 01/28/25 and a 52-week low of $88.57 on 01/10/25. A 50-day SMA is recorded $91.85, while a 200-day SMA reached $79.38. Nevertheless, trading volume fell to 5.58 million shares from 7.41 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 94.47, which, if violated, would cause prices to drop to 93.35. In the upper region, resistance lies at 96.32. The next price resistance is at 97.05. RSI (Relative Strength Index) is 63.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.60, which suggests the price will increase in the coming days. Percent R is at 13.65%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
